What's breaking now, across thousands of outlets.
The agencies will provide a virtual environment for payers and providers to test electronic prior authorization as a federal deadline looms.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The data on which the FDA’s warning is based suggests a real but low risk of NAION for people taking GLP-1 medications.
Palghar, Maharashtra: A total of 120 patients benefited from a free health check-up camp organised at Datiware in the Saphale area of Palghar taluka by the Chief Minister’s Relief Fund and Charitable…
Nigerian internet personality known as Blessing CEO has come out to say her much-talked-about breast cancer battle never happened.
Liquid biopsies already help guide treatment, but researchers wanted to see if they can be used to diagnose people too.
Plus, news about Merck KGaA, Rezolute, Vir, Orakl and Cellectis. Regeneron’s mid-stage POTS data: The biotech’s monoclonal antibody, baloncibart, given at 450 mg led to an average 11.4-beat-per-minute…
In July 2026 the committee voted 8-6 to expand access to six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500.
